XENE
Xenon Pharmaceuticals Inc

2,649
Mkt Cap
$3.18B
Volume
542,441.00
52W High
$46.60
52W Low
$26.74
PE Ratio
-10.59
XENE Fundamentals
Price
$40.39
Prev Close
$41.15
Open
$41.11
50D MA
$42.87
Beta
0.80
Avg. Volume
1.06M
EPS (Annual)
-$3.01
P/B
5.67
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Consensus Recommendation of "Buy" from Analysts
Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) has received an average rating of "Buy" from the fourteen research firms that are covering the firm, Marketbeat.com reports. One analyst has...
MarketBeat·11d ago
News Placeholder
More News
News Placeholder
Xenon Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:XENE)
Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) saw some unusual options trading on Wednesday. Stock traders acquired 4,063 put options on the stock. This represents an increase of 2,362...
MarketBeat·15d ago
News Placeholder
Campbell & CO Investment Adviser LLC Takes Position in Xenon Pharmaceuticals Inc. $XENE
Campbell & CO Investment Adviser LLC purchased a new position in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) in the third quarter, according to the company in its most recent...
MarketBeat·18d ago
News Placeholder
Xenon Pharmaceuticals (NASDAQ:XENE) Hits New 12-Month High - Time to Buy?
Xenon Pharmaceuticals (NASDAQ:XENE) Reaches New 12-Month High - Still a Buy...
MarketBeat·1mo ago
News Placeholder
Xenon Pharmaceuticals (NASDAQ:XENE) CEO Ian Mortimer Sells 40,000 Shares
Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) CEO Ian Mortimer sold 40,000 shares of the company's stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an...
MarketBeat·1mo ago
News Placeholder
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Consensus Recommendation of "Buy" from Brokerages
Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) has been assigned a consensus recommendation of "Buy" from the fourteen analysts that are presently covering the company, MarketBeat...
MarketBeat·1mo ago
News Placeholder
Xenon Pharmaceuticals (NASDAQ:XENE) Trading 3.8% Higher - Here's Why
Xenon Pharmaceuticals (NASDAQ:XENE) Shares Up 3.8% - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Traders Purchase High Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE)
Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) was the target of unusually large options trading on Wednesday. Stock traders bought 4,063 put options on the stock. This is an increase of...
MarketBeat·1mo ago
News Placeholder
Xenon Pharmaceuticals (NASDAQ:XENE) Given New $48.00 Price Target at Wells Fargo & Company
Wells Fargo & Company increased their price target on Xenon Pharmaceuticals from $44.00 to $48.00 and gave the stock an "overweight" rating in a research report on Thursday...
MarketBeat·2mo ago
News Placeholder
Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)
Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) was the recipient of unusually large options trading on Wednesday. Traders acquired 4,063 put options on the stock. This represents an...
MarketBeat·2mo ago
<
1
2
...
>

Latest XENE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.